1. Home
  2. EBS vs XPER Comparison

EBS vs XPER Comparison

Compare EBS & XPER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

N/A

Current Price

$5.10

Market Cap

303.3M

Sector

Health Care

ML Signal

N/A

Logo Xperi Inc.

XPER

Xperi Inc.

N/A

Current Price

$5.37

Market Cap

271.2M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
EBS
XPER
Founded
1998
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
303.3M
271.2M
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
EBS
XPER
Price
$5.10
$5.37
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$10.00
★ $11.40
AVG Volume (30 Days)
★ 946.0K
399.2K
Earning Date
11-02-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 125.83
N/A
EPS
N/A
★ N/A
Revenue
★ $742,900,000.00
$448,105,000.00
Revenue This Year
N/A
$1.90
Revenue Next Year
$7.03
$4.49
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$4.36
$4.91
52 Week High
$14.06
$8.75

Technical Indicators

Market Signals
Indicator
EBS
XPER
Relative Strength Index (RSI) 27.56 40.53
Support Level $4.36 $4.91
Resistance Level $7.18 $5.92
Average True Range (ATR) 0.42 0.27
MACD -0.10 -0.04
Stochastic Oscillator 3.79 13.93

Price Performance

Historical Comparison
EBS
XPER

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

About XPER Xperi Inc.

Xperi Inc is a media and entertainment technology company. Its technologies are integrated into consumer devices, connected cars, and a variety of media platforms globally, enabling audiences to connect with entertainment content in a more intelligent, immersive, and personal way. As its audiences engage with content on the platform, the company operates a cross-screen advertising solution that enables brands to reach millions of engaged consumers across rapidly expanding digital entertainment ecosystem. It operates in one reportable business segment and group its revenue into four categories: Pay-TV, Consumer Electronics, Connected Car and Media Platform. Geographically it operates in U.S. and Canada, Asia Pacific, Europe, Middle East and Africa, and Other countries.

Share on Social Networks: